GLP 1 at Scale
Rise of AI ML-Powered Accelerators in Pharma Secure Supply Chain
The Increasing Importance of Manufacturability in API Development
Digital Quality Management Systems as Strategic Enablers of Patient-Centric Manufacturing Excellence
Redefining RNA Manufacturing Through Innovation in Biocatalysis
EDITORIAL SECTION
-
STRATEGY
Strategic Positioning for M&A
The biotechnology sector is characterised by a constant influx of small highly specialised companies
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solutions help reduce contamination risk and lower manual handling
-
CLINICAL TRIALS
Virtual Clinical Trials
Virtual digital and decentralized are all descriptions of the novel ways that using technology changes
-
Bio Pharma
Biosimilars and Biobetters
Biosimilars are biologic medical products that are essentially identical to an original product manufactured
-
MANUFACTURING
Transformative Convergence of AI in Pharmaceutical Manufacturing
The pharmaceutical manufacturing industry is on the cusp of a revolutionary transformation driven by
-
Information Technology
Transformative Impact of Artificial Intelligence on Clinical Trials
Artificial Intelligence AI has rapidly evolved from a futuristic concept to a transformative tool across various industries
-
EXPERT Talk
Advancing Biopharmaceutical Innovation Through Cell Encapsulation and Biomimetic Therapeutic Systems
My interest in biopharmaceutical engineering began during my senior year as an undergraduate For my capstone project I worked on the encapsulation of...
Advisory Board
.webp "Juris Hmelnickis")
.webp "Eiman Shafa")
KNOWLEDGE BANK
-
Articles
The Translational Gap Is Killing Your Best Molecules
In todays rapidly evolving drug development landscape the translational gap has emerged as a critical challenge that is fundamentally reshaping how organizations approach research and development Its not just a scientific problem its a strategic imperative
-
Techno Trends
University Researchers Develop CAR T Therapy Candidate for Solid Tumour Treatment
Researchers from the University of Calgary and McMaster University have developed a novel CAR T cell therapy approach targeting treatmentresistant solid tumours
-
Projects
BeOne Medicines Invests US$300 Million to Expand New Jersey Manufacturing Campus
BeOne Medicines has announced a US million expansion of its Princeton West Innovation Campus in Hopewell New Jersey strengthening its US manufacturing and research capabilities
-
Research Insights
Thymidylate synthase inhibitory drugs induce p53-dependent pathways differently
Thymidylate synthase TS is a key enzyme in thymidylate biosynthesis and an established target of chemotherapeutics such as fluorodeoxyuridine FdUR and raltitrexed RTX Inhibition of TS disrupts
-
White Papers
Accelerating In-Vitro Antibody Discovery with Artificial Intelligence
Antibodies have transformed modern medicine reshaping treatment paradigms across autoimmune disorders oncology and infectious diseases As one of the most versatile and successful therapeutic modalities
TOP ARTICLES
-
1
Breakthrough Therapies in 2025: What Patients Need To Know?
Kate Williamson
The ‘magical year’ for medicine could be 2025, when treatment for cancer will become immunological, gene treatment will eliminate inherited diseases, and people will know their own bodies...
-
2
ABM Pharma Tactics US: Unlocking B2B Lead Gen Success
Kate Williamson
The Account-based marketing (ABM) pharma strategies are reshaping the US B2B pharma marketing by focusing the high value accounts rather than the lead volume. Pharmaceutical account-based marketing en...
-
3
Challenges and Opportunities in Market Access for New Drugs
Kate Williamson
Navigating market access for new drugs involves overcoming regulatory hurdles, high development costs, clinical trial challenges, and pricing issues. Opportunities include innovative regulatory pathwa...
-
4
Patient-Centric Approaches in Clinical Trials
Vasudev Bhupathi
Patient-centric clinical trials embed participants’ needs at every stage, co-designed protocols, decentralized visits, digital health tools, diversity metrics, and transparent results. This para...
-
5
Pharma Smart Manufacturing: Leveraging IoT and Digital Twins for Next-Gen Production
Kate Williamson
Pharma smart manufacturing is a combination of IoT, digital twin, and high-level automation in order to revolutionize the pharmaceutical production. Smart manufacturing in pharma allows streamlining o...
press releasesRead more...
Moderna Announces Initiation of Phase 1 Clinical Trial of mRNA-1469, Moderna's Investigational Vaccine Against Bundibugyo Ebolavirus
Moderna Inc NASDAQMRNA today announced that following Health Canadas authorization of the study the first participants have been vaccinated in a Phase clinical study in Canada evaluating
Genesis AEC Highlights Programmatic Approach to Laboratory Design
Genesis AEC a consulting engineering firm specializing in pharmaceutical water and utility systems is highlighting its programmatic approach to laboratory design which helps organizations establish a clear foundation for facility planning before design development begins By combining scientific unde...
Labcorp Launches FDA-Approved PTEN Companion Diagnostic for Prostate Cancer
Labcorp NYSE LH a global leader of innovative and comprehensive laboratory services announced the nationwide availability of Roches VENTANA PTEN SP RxDx Assay the first immunohistochemistry IHC
Satellite Bio Announces FDA Rare Pediatric Disease Designation for SB-101 for the Treatment of Urea Cycle Disorders (UCDs)
Satellite Biosciences Inc Satellite Bio a biotechnology company developing offtheshelf liver therapies designed to restore liver function in patients with severe liver diseases today announced that the US Food and Drug
Events Read more...
11 - 12
Aug 2026Medical Device Safety Monitoring and Reporting
San Diego, CA, USA
19 - 21
Aug 2026ISPE Conference & Exhibition 2026
Suntec Singapore
20 - 21
Aug 2026Pharmaceutical Formulations 2026
London, UK
20 - 21
Aug 2026Novel Drug Delivery Systems 2026
London, UK
20 - 21
Aug 2026Advanced Clinical Research 2026
London, UK
25 - 27
Aug 2026CPHI Korea 2026
COEX, Seoul, Korea
26 - 27
Aug 2026BIOMEDevice 2026
Boston Convention & Exhibition...
03 - 05
Sep 20265th MENA Congress for Rare Diseases 2026
Beach Rotana Hotel, Abu Dhabi,...
LATEST NEWSRead more...
Lunai Bioworks partners with BrainStorm Therapeutics to advance precision therapies for Parkinson’s disease
Lunai Bioworks has signed a definitive collaboration agreement with BrainStorm Therapeutics to advance the discovery of diseasemodifying therapies for Parkinsons disease The companies are targeting an initial data readout from the collaboration in the first half of
SHY Therapeutics doses first patient in Phase 1 trial of SHY-ONC6 for solid tumours
SHY Therapeutics has dosed the first patient in its firstinhuman Phase clinical trial evaluating SHYONC an investigational oral proteasome inhibitor for the treatment of advanced solid tumours The company expects to report initial Phase data in
Taysha Gene Therapies and Catalent Expand Partnership for Future Commercial Manufacturing of TSHA-102
Taysha Gene Therapies and Catalent have expanded their strategic partnership through a commercial supply agreement for TSHA Tayshas investigational gene therapy for Rett syndrome
Pathos AI Signs Global Licensing Agreement with Alphamab Oncology for JSKN016 Bispecific ADC
Pathos AI has entered into a global licensing agreement with Jiangsu Alphamab Biopharmaceuticals a wholly owned subsidiary of Alphamab Oncology for JSKN a firstinclass TROPHER bispecific
Rose Hill Life Sciences and Control Z Partner to Advance Psilocybin-Assisted Therapy for PTSD
Rose Hill Life Sciences has signed a Letter of Intent LOI with Control Z to develop a clinically structured psilocybinassisted therapy programme for posttraumatic stress disorder PTSD through Rose Hills Psychedelic Therapeutic Intervention PTI platform
FDA Approves Meitheal’s Garzulys Biosimilar Insulin for Diabetes Treatment
Meitheal Pharmaceuticals has announced that the US Food and Drug Administration FDA has approved Garzulys insulin aspartfsan injection a biosimilar to NovoLog insulin aspart for the treatment of diabetes mellitus
